preloader image
Break The Chain
down arrow image DOWNLOAD
Annual Report 2020-21
chain image

Highlights of the Year

For the first time, 8 Lakhs new customers used Metropolis for COVID-19 tests. In H2FY21, we saw a healthy conversion rate of 10% of customers who tried Metropolis for a Non-COVID Test. We anticipate higher conversion rates in the coming quarters.

Our Non-COVID business over the last year

FY20 Revenue

list block

FY21 Non-COVID Revenue

list block image
  • 998 Crores, up 17%
    Revenue in FY21 and Percentage
    Growth as Compared to FY20
  • 288 Crores
  • 183 Crores, up 44%
    PAT in FY20 and Percentage
    Growth as Compared to FY20
  • 58%, up 200 bps
    Percentage Revenue Share
    of B2C in Focus Cities
  • 9.8 Million
    Patient Visits
  • 19.0 Million
    Tests Conducted in FY20-21

EBIDTA: Earnings Before Interest, Depreciation, Taxes and Amortisation |PAT: Profit after Tax |B2C: Business to Customers


One of the leading players in the Indian diagnostic space

Incepted in the year 1980, Metropolis is among is among the leading diagnostics players in India, with a dominant share in the country’s western and southern region. Metropolis offers a comprehensive range of 4,000+ clinical laboratory tests and profiles as one of the market leaders. These tests are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of different diseases. Additionally, the Company also offers analytical and support services to clinical research organisations for their clinical research projects. Growing strength by strength, the Company has spread its footprints across 19 Indian states and 210 cities.

  • 35
    Years Of Credible
  • 2,555
    Patient Service
  • 125
    Clinical Laboratories
  • ~4,000
    Tests and Profiles
  • 20
    Presence Across
    Indian States
  • 10,000+
    Patients Touchpoints
  • ~220
    Presence across
    Indian Cities
  • ~9,000
    Pick-up Points
  • 498
    Assisted Referral
    Centres (ARC)
  • 25
    NABL Accredited Labs

All figures as on March 31, 2021

Why Metropolis?

  • Conclusive diagnosis with extensive test menu backed by highest standards of quality
  • Customer-focussed services with convenience and test accuracy at the core of service standard
  • Wide and unparalleled service network with pan-India presence
  • Consistency in operations at every single visit from seamless blood collection, hygienic collection setup to timely report delivery


  • Mumbai Lab is CAP accredited since 2005
  • NABL accreditation
  • More than 75% reports are
    generated by accredited labs
  • NABL accreditation follows ISO-15189
    Standard and is recognised by ILAC & APLAC

*CAP: College of American Pathologists *NABL: National Accreditation Board for Testing and Calibration Laboratories


vision icon

To be a respected healthcare brand trusted by clinicians, patients and stakeholders. Positively impact lives of patients in their most anxious times and turn their anxiety in to assurance.


mission icon

Helping people stay healthy, by accurately revealing their inner health.


values icon
values image
mvo image
mvo image
green angle